• Filing Date: 2016-03-30
  • Form Type: 10-K
  • Description: Annual report
v3.3.1.900
LICENSE AGREEMENTS (Details Textual)
1 Months Ended 12 Months Ended
Feb. 27, 2015
USD ($)
Dec. 27, 2013
USD ($)
Dec. 31, 2015
USD ($)
shares
Dec. 31, 2015
EUR (€)
shares
LICENSE AGREEMENTS [Line Items]        
Additional Milestone Payments to be Received Contingent upon Exercise of Options   $ 325,000,000    
Payments for Royalties | €       € 20,000
Medtronic [Member]        
LICENSE AGREEMENTS [Line Items]        
Upfront Payment     $ 100,000  
Additional Milestone Payable Maximum Amount     7,000,000  
Exosomes License Agreement [Member]        
LICENSE AGREEMENTS [Line Items]        
Upfront Payment     20,000  
Additional Milestone Payable Maximum Amount $ 190,000      
Reimbursed Expenses to be Paid 34,000      
Janssen Agreement [Member]        
LICENSE AGREEMENTS [Line Items]        
Payment For Development Fee   $ 12,500,000    
Minimum [Member]        
LICENSE AGREEMENTS [Line Items]        
Development Milestones     350,000  
Maximum [Member]        
LICENSE AGREEMENTS [Line Items]        
Development Milestones     800,000  
Maximum [Member] | JHU License Agreement [Member]        
LICENSE AGREEMENTS [Line Items]        
Accrued Milestone Payments     1,850,000  
Completion of Phase One [Member]        
LICENSE AGREEMENTS [Line Items]        
Range of Milestone Payments, Payable Upon Successful Completion of Certain Phases     100,000  
Completion of Phase One [Member] | Exosomes License Agreement [Member]        
LICENSE AGREEMENTS [Line Items]        
Milestone Payments To Be Made Upon Successful Completion Of Certain Phases 15,000      
Completion of Phase One [Member] | Minimum [Member]        
LICENSE AGREEMENTS [Line Items]        
Range of Milestone Payments, Payable Upon Successful Completion of Certain Phases     100,000  
Obtention of FDA Approval [Member] | Exosomes License Agreement [Member]        
LICENSE AGREEMENTS [Line Items]        
Milestone Payments To Be Made Upon Successful Completion Of Certain Phases $ 75,000      
Obtention of FDA Approval [Member] | Maximum [Member]        
LICENSE AGREEMENTS [Line Items]        
Range of Milestone Payments, Payable Upon Successful Completion of Certain Phases     $ 1,000,000  
Mayo License Agreement [Member]        
LICENSE AGREEMENTS [Line Items]        
Common Stock Issued as Additional Consideration for Grant of Certain Rights | shares     18,000 18,000
First and Second Anniversary [Member]        
LICENSE AGREEMENTS [Line Items]        
Payments for Royalties     $ 5,000  
Tenth Anniversary and Thereafter [Member]        
LICENSE AGREEMENTS [Line Items]        
Payments for Royalties     $ 20,000